PATL1 and neoplasm: In particular, expression of lrrn1, patl1 and psip1a were highly specific to tumor cells; 0% of normal thymus and less than 3% preleukemic samples were positive for all three genes, while up to 46% of tumor samples were positive (Supplementary Fig. 5F).